Literature DB >> 12488200

Increased expression of alpha-1-antitrypsin, glutathione S-transferase pi and vascular endothelial growth factor in human pancreatic adenocarcinoma.

Aaron L Trachte1, Sara E Suthers, Megan R Lerner, Jay S Hanas, Eldon R Jupe, Anna E Sienko, Adekunle M Adesina, Stan A Lightfoot, Daniel J Brackett, Russell G Postier.   

Abstract

BACKGROUND: This study was designed to investigate abnormalities in gene expression in ductal adenocarcinoma of the pancreas using cDNA arrays.
METHODS: Gene expression in pancreatic ductal adenocarcinoma was compared with normal pancreatic tissue controls. Specimens from 5 patients with pancreatic adenocarcinoma were taken fresh at operation and analyzed using commercially prepared cDNA arrays evaluating approximately 2,000 genes. Immunohistochemical staining was used to confirm protein expression of selected genes.
RESULTS: Alpha-1-antitrypsin (A1AT) and glutathione S-transferase pi (GSTP) were significantly up-regulated in all 5 tumors. Vascular endothelial growth factor (VEGF) was up-regulated in 4 of the 5 patients. Immunohistochemical staining verified the overexpression of each of these genes.
CONCLUSIONS: A1AT, GSTP, and VEGF are overexpressed in human pancreatic adenocarcinoma specimens taken fresh at operation. To our knowledge, this is the first study of human pancreatic ductal adenocarcinoma demonstrating the up-regulation of these genes using gene expression arrays.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12488200     DOI: 10.1016/s0002-9610(02)01105-4

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  8 in total

1.  Genetic effects and modifiers of radiotherapy and chemotherapy on survival in pancreatic cancer.

Authors:  Hongmei Zeng; Herbert Yu; Lingeng Lu; Dhanpat Jain; Mark S Kidd; M Wasif Saif; Stephen J Chanock; Patricia Hartge; Harvey A Risch
Journal:  Pancreas       Date:  2011-07       Impact factor: 3.327

2.  Glutathione S-transferase gene polymorphisms and risk and survival of pancreatic cancer.

Authors:  Li Jiao; Melissa L Bondy; Manal M Hassan; David Z Chang; James L Abbruzzese; Douglas B Evans; Michael H Smolensky; Donghui Li
Journal:  Cancer       Date:  2007-03-01       Impact factor: 6.860

3.  Novel compound 1,3-bis (3,5-dichlorophenyl) urea inhibits lung cancer progression.

Authors:  Sharad S Singhal; James Figarola; Jyotsana Singhal; Lokesh Nagaprashantha; David Berz; Samuel Rahbar; Sanjay Awasthi
Journal:  Biochem Pharmacol       Date:  2013-10-04       Impact factor: 5.858

4.  Nrf2 is overexpressed in pancreatic cancer: implications for cell proliferation and therapy.

Authors:  Adam Lister; Taoufik Nedjadi; Neil R Kitteringham; Fiona Campbell; Eithne Costello; Bryony Lloyd; Ian M Copple; Samantha Williams; Andrew Owen; John P Neoptolemos; Chris E Goldring; B Kevin Park
Journal:  Mol Cancer       Date:  2011-04-13       Impact factor: 27.401

5.  Alpha-1 Antitrypsin Blood Levels as Indicator for the Efficacy of Cancer Treatment.

Authors:  Zeyad J El-Akawi; Aymen M Abu-Awad; Nabil A Khouri
Journal:  World J Oncol       Date:  2013-05-06

6.  Multiplexed Detection of Pancreatic Cancer by Combining a Nanoparticle-Enabled Blood Test and Plasma Levels of Acute-Phase Proteins.

Authors:  Damiano Caputo; Alessandro Coppola; Erica Quagliarini; Riccardo Di Santo; Anna Laura Capriotti; Roberto Cammarata; Aldo Laganà; Massimiliano Papi; Luca Digiacomo; Roberto Coppola; Daniela Pozzi; Giulio Caracciolo
Journal:  Cancers (Basel)       Date:  2022-09-25       Impact factor: 6.575

7.  Tissue and serum samples of patients with papillary thyroid cancer with and without benign background demonstrate different altered expression of proteins.

Authors:  Mardiaty Iryani Abdullah; Ching Chin Lee; Sarni Mat Junit; Khoon Leong Ng; Onn Haji Hashim
Journal:  PeerJ       Date:  2016-09-13       Impact factor: 2.984

8.  A panel of glycoproteins as candidate biomarkers for early diagnosis and treatment evaluation of B-cell acute lymphoblastic leukemia.

Authors:  Marcio de Souza Cavalcante; José Camilo Torres-Romero; Marina Duarte Pinto Lobo; Frederico Bruno Mendes Batista Moreno; Leonardo Primo Bezerra; Diego Silva Lima; Jesamar Correia Matos; Renato de Azevedo Moreira; Ana Cristina de Oliveira Monteiro-Moreira
Journal:  Biomark Res       Date:  2016-01-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.